Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04631744
Title Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Weill Medical College of Cornell University
Indications

prostate carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST